Study of molecular dynamics and cross relaxation in tetramethylammonium hexafluorophosphate (CH3)4NPF6 by 1H and 19F NMR

(CH3)4NPF6 is studied by NMR measurements to understand the internal motions and cross relaxation mechanism between the heterogeneous nuclei. The spin lattice relaxation times (T1) are measured for 1H and 19F nuclei, at three (11.4, 16.1 and 21.34 MHz) Larmor frequencies in the temperature range 350-50 K and 1H NMR second moment measurements at 7 MHz in the temperature range 300-100 K employing home made pulsed and wide-line NMR spectrometers. 1H NMR results are attributed to the simultaneous reorientations of both methyl and tetramethylammonium groups and motional parameters are evaluated. 19F NMR results are attributed to cross relaxation between proton and fluorine and motional parameters for the PF6 group reorientation are evaluated. © 2008 Elsevier Inc. All rights reserved

1H and 19F NMR relaxation time studies in (NH4)2ZrF6 superionic conductor

1H and 19F spin-lattice relaxation times in polycrystalline diammonium hexafluorozirconate have been measured in the temperature range of 10–400 K to elucidate the molecular motion of both cation and anion. Interesting features such as translational diffusion at higher temperatures, molecular reorientational motion of both cation and anion groups at intermediate temperatures and quantum rotational tunneling of the ammonium group at lower temperatures have been observed. Nuclear magnetic resonance (NMR) relaxation time results correlate well with the NMR second moment and conductivity studies reported earlier

H-1 NMR study of internal motions and quantum rotational tunneling in (CH3)(4)NGeCl3

(CH3)(4)NGeCl3 is prepared, characterized and studied using H-1 NMR spin lattice relaxation time and second moment to understand the internal motions and quantum rotational tunneling. Proton second moment is measured at 7 MHz as function of temperature in the range 300-77 K and spin lattice relaxation time (T-1) is measured at two Larmor frequencies, as a function of temperature in the range 270-17 K employing a homemade wide-line/pulsed NMR spectrometers. T-1 data are analyzed in two temperature regions using relevant theoretical models. The relaxation in the higher temperatures (270-115 K) is attributed to the hindered reorientations of symmetric groups (CH3 and (CH3)(4)N). Broad asymmetric T-1 minima observed below 115 K down to 17 K are attributed to quantum rotational tunneling of the inequivalent methyl groups. Copyright (c) 2007 John Wiley & Sons, Ltd

Study of molecular reorientation and quantum rotational tunneling in tetramethylammonium selenate by 1H NMR

1H NMR spin-lattice relaxation time measurements have been carried out in [(CH3)4N]2SeO4 in the temperature range 389-6.6 K to understand the possible phase transitions, internal motions and quantum rotational tunneling. A broad T1 minimum observed around 280 K is attributed to the simultaneous motions of CH3 and (CH3)4N groups. Magnetization recovery is found to be stretched exponential below 72 K with varying stretched exponent. Low-temperature T1 behavior is interpreted in terms of methyl groups undergoing quantum rotational tunneling. © 2007 Elsevier Inc. All rights reserved

Determination of Phase Composition of Cobalt Nanoparticles Using 59Co Internal Field Nuclear Magnetic Resonance

It is well known that cobalt exhibits polymorphism, i.e., the co-existence of both the hcp and fcc phases. In particular, the method of synthesis and other thermodynamic conditions is known to play a crucial role in determining the particular phase of cobalt. In this work, we have compared the phase composition of the cobalt nanoparticles synthesized using two different solvents (water) and ethanol (Co@C). XRD measurements confirm the existence of fcc phase in commercial cobalt nanoparticles (Co@A), co-existence of fcc and hcp phases in Co@B, while the existence of the hcp phase in Co@C. We have studied these cobalt nanoparticles using 59Co internal field nuclear magnetic resonance (IFNMR) for verification of phase composition. Our studies reveal that the Co@A has fcc as a major phase with minor quantity hcp phase. Co@B exhibits approximately equal amount of fcc and hcp phase while Co@C exhibits hcp as a major phase with minor fcc phase. Our SEM micrograph studies confirm that the cobalt particles have spherical shape in the fcc phase. The cobalt particles exhibit both spherical and dendrite morphology confirming the co-existence of fcc and hcp phases, while the sample with pure hcp phase exhibits the dendrite morphology. Our studies also throw light on understanding the effect of solvent in the phase formation of the cobalt nanoparticles

Determination of Phase Composition of Cobalt Nanoparticles Using 59Co Internal Field Nuclear Magnetic Resonance

It is well known that cobalt exhibits polymorphism, i.e., the co-existence of both the hcp and fcc phases. In particular, the method of synthesis and other thermodynamic conditions is known to play a crucial role in determining the particular phase of cobalt. In this work, we have compared the phase composition of the cobalt nanoparticles synthesized using two different solvents (water) and ethanol (Co@C). XRD measurements confirm the existence of fcc phase in commercial cobalt nanoparticles (Co@A), co-existence of fcc and hcp phases in Co@B, while the existence of the hcp phase in Co@C. We have studied these cobalt nanoparticles using 59Co internal field nuclear magnetic resonance (IFNMR) for verification of phase composition. Our studies reveal that the Co@A has fcc as a major phase with minor quantity hcp phase. Co@B exhibits approximately equal amount of fcc and hcp phase while Co@C exhibits hcp as a major phase with minor fcc phase. Our SEM micrograph studies confirm that the cobalt particles have spherical shape in the fcc phase. The cobalt particles exhibit both spherical and dendrite morphology confirming the co-existence of fcc and hcp phases, while the sample with pure hcp phase exhibits the dendrite morphology. Our studies also throw light on understanding the effect of solvent in the phase formation of the cobalt nanoparticles

Fabrication of high quality plan-view TEM specimens using the focused ion beam

We describe a technique using a focused ion beam instrument to fabricate high quality plan-view specimens for transmission electron microscopy studies. The technique is simple, site-specific and is capable of fabricating multiple large, >100 μm2 electron transparent windows within epitaxially-grown thin films. A film of La0.67Sr0.33MnO3 is used to demonstrate the technique and its structural and functional properties are surveyed by high resolution imaging, electron spectroscopy, atomic force microscopy and Lorentz electron microscopy. The window is demonstrated to have good thickness uniformity and a low defect density that does not impair the film’s Curie temperature. The technique will enable the study of in–plane structural and functional properties of a variety of epitaxial thin film systems

Prevalence of frailty and association with patient centered outcomes:A prospective registry-embedded cohort study from India

Purpose:We aimed to study the prevalence of frailty, evaluate risk factors, and understand impact on outcomes in India. Methods:This was a prospective registry-embedded cohort study across 7 intensive care units (ICUs) and included adult patients anticipated to stay for at least 48hrs. Primary exposure was frailty, as defined by a score ≥5 on the Clinical Frailty Scale and primary outcome was ICU mortality. Secondary outcomes included in-hospital mortality and resource utilization. We used generalized linear models to evaluate risk factors and model association between frailty and outcomes. Results:838 patients were included, with median (IQR) age 57 (42,68) yrs.; 64.8% were male. Prevalence of frailty was 19.8%. Charlson comorbidity index (OR:1.73 (95%CI:1.39,2.15)), Subjective Global Assessment categories mild/moderate malnourishment (OR:1.90 (95%CI:1.29, 2.80)) and severe malnourishment [OR:4.76 (95% CI:2.10,10.77)] were associated with frailty. Frailty was associated with higher odds of ICU mortality (adjusted OR:2.04 (95% CI:1.25,3.33)), hospital mortality (adjusted OR:2.36 (95%CI:1.45,3.84)), development of stage2/3 AKI (unadjusted OR:2.35 (95%CI:1.60, 3.43)), receipt of non-invasive ventilation (unadjusted OR:2.68 (95%CI:1.77, 4.03)), receipt of vasopressors (unadjusted OR:1.47 (95%CI:1.04, 2.07)), and receipt of kidney replacement therapy (unadjusted OR:3.15 (95%CI:1.90, 5.17)). Conclusions:Frailty is common among critically ill patients in India and is associated with worse outcomes. <br/

Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations

Background: Tuberous sclerosis complex (TSC) is an inherited neurocutaneous disorder caused by mutations in the TSC1 or TSC2 genes, with patients often exhibiting neurodevelopmental (ND) manifestations termed TSC-associated neuropsychiatric disorders (TAND) including autism spectrum disorder (ASD) and intellectual disability. Hamartin (TSC1) and tuberin (TSC2) proteins form a complex inhibiting mechanistic target of rapamycin complex 1 (mTORC1) signaling. Loss of TSC1 or TSC2 activates mTORC1 that, among several targets, controls protein synthesis by inhibiting translational repressor eIF4E-binding proteins. Using TSC1 patient-derived neural progenitor cells (NPCs), we recently reported early ND phenotypic changes, including increased cell proliferation and altered neurite outgrowth in TSC1-null NPCs, which were unaffected by the mTORC1 inhibitor rapamycin. Methods: Here, we used polysome profiling, which quantifies changes in mRNA abundance and translational efficiencies at a transcriptome-wide level, to compare CRISPR-edited TSC1-null with CRISPR-corrected TSC1-WT NPCs generated from one TSC donor (one clone/genotype). To assess the relevance of identified gene expression alterations, we performed polysome profiling in postmortem brains from ASD donors and age-matched controls. We further compared effects on translation of a subset of transcripts and rescue of early ND phenotypes in NPCs following inhibition of mTORC1 using the allosteric inhibitor rapamycin versus a third-generation bi-steric, mTORC1-selective inhibitor RMC-6272. Results: Polysome profiling of NPCs revealed numerous TSC1-associated alterations in mRNA translation that were largely recapitulated in human ASD brains. Moreover, although rapamycin treatment partially reversed the TSC1-associated alterations in mRNA translation, most genes related to neural activity/synaptic regulation or ASD were rapamycin-insensitive. In contrast, treatment with RMC-6272 inhibited rapamycin-insensitive translation and reversed TSC1-associated early ND phenotypes including proliferation and neurite outgrowth that were unaffected by rapamycin. Conclusions: Our work reveals ample mRNA translation alterations in TSC1 patient-derived NPCs that recapitulate mRNA translation in ASD brain samples. Further, suppression of TSC1-associated but rapamycin-insensitive translation and ND phenotypes by RMC-6272 unveils potential implications for more efficient targeting of mTORC1 as a superior treatment strategy for TAND